Amino Acid Metabolism - V

Tryptophan Degradation: Tryptophan and Kynurenines
  • Overview: Tryptophan catabolism feeds two major routes with distinct enzymes and outcomes:
    • Kynurenine pathway (major route for tryptophan degradation to NAD+ and other metabolites)
    • Serotonin/melatonin pathway (alternative route yielding neurotransmitters)
  • Key enzymes and pathways
    • Indoleamine 2,3-dioxygenase (IDO1, IDO2) and Tryptophan 2,3-dioxygenase (TDO)
    • Initial step: Tryptophan \rightarrow N-formylkynurenine via IDO/TDO. IDO activity is often induced by inflammatory cytokines like Interferon gamma (IFN-\gamma), linking immune responses to tryptophan metabolism.
    • Formamidase then converts N-formylkynurenine to kynurenine
  • Kynurenine branch points and products
    • Kynurenine \rightarrow kynurenic acid (via kynurenine aminotransferase, KAT). Kynurenic acid is generally considered neuroprotective as an NMDA receptor antagonist.
    • Kynurenine \rightarrow 3-hydroxykynurenine (via kynurenine 3-m hydroxylase, KMO pathway)
    • 3-hydroxykynurenine \rightarrow 3-hydroxyanthranilic acid
    • 3-hydroxyanthranilic acid \rightarrow quinolinic acid (Q) \rightarrow NAD+ synthesis final steps. Quinolinic acid is a known neurotoxin and NMDA receptor agonist, whose accumulation is implicated in neurodegenerative diseases.
    • Formate produced along the pathway; downstream NAD generation
    • Nicotinamide adenine dinucleotide (NAD) production from the kynurenine pathway via quinolinic acid
    • Alternative branch: Tryptophan \rightarrow 5-hydroxytryptophan (5-HTP) via tryptophan hydroxylase (TPH) \rightarrow serotonin via aromatic L-amino acid decarboxylase (AADC)
    • Melatonin branch: serotonin \rightarrow melatonin via N-acetyltransferase and hydroxyindole O-methyltransferase (HIOMT)
  • Related biological roles and implications
    • Brain, skeletal muscle, immune system, gut, microbiome interactions
    • Balance between neurotoxic and neuroprotective outcomes: Neurotoxicity (e.g., by quinolinic acid) vs neuroprotection (e.g., by kynurenic acid) depending on pathway flux and local concentrations.
    • Immune modulation and cancer implications: IDO activity influences immune tolerance by depleting tryptophan in the microenvironment and producing immunomodulatory kynurenines, and may be a pharmacological target in cancer therapy to overcome immune evasion.
    • Niacin (nicotinamide) production via the kynurenine pathway contributes to vitamin B3 supply
    • One-carbon metabolism connection: formate can feed into one-carbon pools via THF
  • Clinical and physiological notes
    • Tryptophan degradation products influence mood, inflammation, mucosal homeostasis, and host–microbiome interactions
    • IDO as a pharmacological target for cancer therapy due to its immunomodulatory effects
Branched-Chain Amino Acids (BCAA) Catabolism and Maple Syrup Urine Disease (MSUD)
  • Major pathway and enzymes
    • Branched-chain aminotransferase (BCAT): transfers amino group from BCAAs (leucine, isoleucine, valine) to \alpha-ketoglutarate, yielding branched-chain \alpha-keto acids (BCKAs) and glutamate
    • Branched-chain \alpha-keto acid dehydrogenase complex (BCKD): the rate-limiting, multi-enzyme complex that decarboxylates BCKAs; comprised of three catalytic components (E1, E2, E3):
    • E1: Thiamine pyrophosphate (TPP)-dependent decarboxylase
    • E2: Dihydrolipoyl transacylase (lipoate-dependent)
    • E3: Dihydrolipoyl dehydrogenase (FAD and NAD+-dependent)
    • Cofactors include TLCFN:
    • TPP (thiamine pyrophosphate)
    • Lipoate
    • CoA
    • FAD
    • NAD+
    • Downstream degradation to acetyl-CoA and/or succinyl-CoA derivatives feeding into the TCA cycle
  • Leucine, isoleucine, valine fates (conceptual)
    • Leucine degradation: leucine \rightarrow isovaleryl-CoA \rightarrow 3-methylcrotonyl-CoA \rightarrow 3-methylglutaconyl-CoA \rightarrow HMG-CoA derivatives \rightarrow acetyl-CoA and acetoacetate
    • Isoleucine and valine degradation lead to succinyl-CoA and acetyl-CoA derivatives, feeding into the TCA cycle
    • Overall yield: acetyl-CoA and/or succinyl-CoA units for energy and biosynthesis
  • Maple Syrup Urine Disease (MSUD)
    • Cause: deficiency of branched-chain \alpha-keto acid dehydrogenase (BCKD), primarily affecting the E1 component in most cases.
    • Phenotype: accumulation of BCAAs and BCKAs, leading to urine with a characteristic maple sugar odor; vomiting; lethargy; poor feeding; and potential severe, irreversible brain damage due to neurotoxic effects if untreated. The accumulation of BCKAs (especially \alpha-ketoisocaproate) impairs brain energy metabolism and neurotransmitter synthesis.
    • Therapy: strict dietary management with reduced intake of branched-chain amino acids (leucine, isoleucine, valine) is critical from birth.
    • Epidemiology: autosomal recessive; global incidence \sim 1 in 185,000 newborns; higher frequency in inbred Mennonite population of Lancaster County, PA \sim 1 in 175 newborns)
    • Additional notes
    • Accumulation of BCAAs and BCKAs can be neurotoxic; careful dietary control is essential to prevent metabolic crises and neurological damage.
Degradation of Histidine: Enzymes, Products, and Histidinemia
  • Histidine catabolic pathway
    • Histidine \rightarrow urocanate via histidase (histidine ammonia-lyase)
    • Urocanate \rightarrow imidazolone propionate via urocanase. Urocanate is abundant in the stratum corneum of the skin, where it acts as a natural sunscreen and modulator of immune responses.
    • Imidazolone propionate \rightarrow N-formimino-glutamate (FIGLU) via imidazolone propionate hydrolase
    • THF-dependent steps: THFA-formimino transferase converts formimino group to THF, yielding N^5-formimino-THF and glutamate
    • Intermediate: FIGLU can donate a one-carbon unit to THF to become glutamate and form formiminoglutamate derivatives; continuation yields glutamate and downstream TCA cycle intermediates (via \alpha-ketoglutarate)
  • Enzymes involved (numbered as in slide):
    • 1 = Histidase
    • 2 = Urocanase
    • 3 = Imidazolone propionate hydrolase
    • 4 = THFA-formimino transferase
  • Clinical correlation: Histidinemia
    • Cause: deficiency of histidase. This leads to elevated levels of histidine in blood and urine, and a lack of urocanate in the skin.
    • Frequency: approximately 1 in 10,000 individuals
    • Tissue expression: histidase is highly expressed in skin and liver; urocanate present in sweat
    • Diagnosis: histidase deficiency can be confirmed via skin biopsy or by measuring histidine levels in blood. While historically associated with speech problems or intellectual disability, many individuals with histidinemia are asymptomatic.
    • Significance: Complete histidine catabolism occurs in the liver; deficiencies lead to metabolic and diagnostic considerations for screening and management
Pathway for the Synthesis of Carnitine and Creatine
  • Carnitine synthesis from lysine
    • Lysine is the precursor
    • Lysine undergoes sequential methylation to form N-trimethyllysine, which is then hydroxylated and cleaved through multiple steps to produce carnitine.
    • Enzymes: S-adenosylmethionine (SAM)-dependent lysine methyltransferases; regulatory steps not all shown, but the pathway culminates in carnitine formation.
    • Functional role: Carnitine is essential for the transport of long-chain fatty acids from the cytosol into the mitochondrial matrix for \beta-oxidation, facilitating energy production from fats.
  • Creatine synthesis
    • Precursors: glycine and arginine
    • Step 1: glycine + arginine \rightarrow guanidinoacetate (enzyme: arginine:glycine amidinotransferase, AGAT; EC 2.1.4.1), primarily occurring in the kidney.
    • Step 2: guanidinoacetate + SAM \rightarrow creatine + SAH (enzyme: guanidinoacetate N-methyltransferase, GAMT; EC 2.1.1.2), primarily occurring in the liver.
    • Step 3: creatine phosphorylation to phosphocreatine (PCr) via creatine kinase: ATP + creatine \rightleftharpoons ADP + phosphocreatine (Cr-P)
    • Fate of creatine: creatine can be phosphorylated to PCr for rapid ATP buffering; spontaneous non-enzymatic cyclization to creatinine (CrN), a waste product excreted in urine. The rate of creatinine formation is relatively constant and proportional to muscle mass.
  • Functional significance
    • PCr serves as a rapid, readily available energy reserve, especially in tissues with fluctuating energy demands like skeletal muscle, heart, and brain; creatine kinase maintains energy homeostasis during high demand by rapidly regenerating ATP from ADP.
    • Creatinine levels in blood/urine are widely used as a biomarker for estimating glomerular filtration rate (GFR) and assessing kidney function, in addition to reflecting muscle mass or damage.
One-Carbon Metabolism from Amino Acids: Role of Folate, Megaloblastic Anemia, and the Folate Trap
  • One-carbon units and folate biology
    • Tetrahydrofolate (THF) acts as a carrier of one-carbon units in various oxidation states (formyl, methenyl, methylene, methyl)
    • Primary donor sources of one-carbon units include serine and glycine metabolism feeding into THF derivatives
  • Folate metabolism and the folate cycle
    • DHF \rightleftharpoons THF cycle: DHF is reduced to THF by dihydrofolate reductase (DHFR)
    • DHFR is inhibited by methotrexate (MTX), a potent anticancer agent; bacterial DHFR is targeted by trimethoprim; protozoan DHFR targeted by pyrimethamine; sulfonamides disrupt bacterial folate synthesis upstream (PABA pathway) – classic antibacterial strategy
    • THF derivatives carry one-carbon units used for nucleotide (purines and thymidylate) and amino acid (e.g., methionine) biosynthesis
  • Specific roles of THF derivatives
    • Formyl-THF (N^{10}\text{-formyl-THF}) donates formyl groups in purine biosynthesis (e.g., at the C2 and C8 positions).
    • \text{5,10-methylene-THF} donates methylene groups for dTMP synthesis, a crucial step for DNA replication.
    • \text{5,10-methenyl-THF/5,10-methylene-THF} interconversion supplies methenyl-THF for other reactions.
    • \text{5-methyl-THF} donates a methyl group for methionine synthesis via transfer to homocysteine.
  • Major reactions and conversions illustrating THF roles
    • Serine \rightleftharpoons glycine interconversion with THF:
    • \text{Serine + THF} \rightleftharpoons \text{Glycine + 5,10-methylene-THF + H2O} (enzyme: serine hydroxymethyltransferase, SHMT). This is a major source of one-carbon units.
    • dTMP (thymidine) synthesis depends on \text{5,10-methylene-THF} as a cofactor:
    • \text{dUMP + 5,10-methylene-THF} \rightarrow \text{dTMP + DHF} (catalyzed by thymidylate synthase). DHF is then re-reduced to THF by DHFR.
    • Purine synthesis relies on one-carbon units from formyl-THF and methenyl-THF.
    • Methionine synthesis requires a methyl-THF donated by \text{5-methyl-THF}; homocysteine \rightarrow methionine:
    • \text{Homocysteine + 5-methyl-THF} \rightarrow \text{Methionine + THF} (catalyzed by methionine synthase with B12 cofactor).
  • The three key processes connected to health
    • Megaloblastic anemia linked to impaired DNA synthesis due to insufficient dTMP/dTTP. This condition is characterized by the presence of large, immature red blood cells (megaloblasts) in the bone marrow and circulating macro-ovalocytes, leading to reduced oxygen-carrying capacity. It also affects other rapidly dividing cells, like those of the immune system and gastrointestinal tract.
    • Folate trap: in vitamin B12 (cobalamin) deficiency, methionine synthesis from homocysteine is impaired because the methyl group from \text{5-methyl-THF} cannot be transferred to homocysteine. This causes \text{5-methyl-THF} to accumulate, trapping folate in this methylated form and effectively depleting other THF forms (e.g., \text{5,10-methylene-THF}) needed for dTMP synthesis.
    • Consequences: impaired cell division, especially in rapidly dividing cells like neutrophils and erythroblasts, leading to conditions like megaloblastic anemia and neutropenia.
  • Practical notes
    • Processes influenced by folate/B12 status include DNA replication, purine and thymidine synthesis, and methionine production
    • Folate status interacts with neural tube development and methylation reactions in the body
    • Examples of therapeutic inhibitors and drugs: MTX (DHFR inhibitor), sulfonamides (PABA pathway inhibition), trimethoprim (bacterial DHFR inhibitor), pyrimethamine (protozoal DHFR inhibitor)
Synthesis of Glycine/Serine and Taurine
  • Serine biosynthesis from 3-phosphoglycerate
    • 3-phosphoglycerate \rightarrow 3-phosphohydroxypyruvate \rightarrow 3-phosphoserine \rightarrow serine
    • Enzymes involved: phosphoglycerate dehydrogenase; phosphoserine phosphatase; serine hydroxymethyltransferase (SHMT) links to THF
  • Serine to glycine and one-carbon metabolism
    • \text{Serine + THF} \rightarrow \text{Glycine + 5,10-methylene-THF + H2O} (SHMT). This reaction provides a crucial link between amino acid metabolism and one-carbon pools.
    • Consequences: glycine serves as a one-carbon donor for purine and heme synthesis, and contributes to overall one-carbon metabolism
  • Role of glycine in metabolism
    • One-carbon donor; collagen synthesis (glycine is abundant in the collagen triple helix, especially every third residue, forming \text{Gly-X-Y} repeats);
    • Heme synthesis; Purine synthesis; Detoxification pathways (e.g., conjugation with bile acids and toxins); acts as an inhibitory neurotransmitter in the central nervous system.
    • Serine/glycine pathways feed into THF-dependent one-carbon pools
  • Taurine synthesis and function
    • Pathway: cysteine \rightarrow cysteine sulfinate \rightarrow hypotaurine \rightarrow taurine. This pathway involves enzymes like cysteine dioxygenase and cysteine sulfinate decarboxylase.
    • Taurine is a sulfur-containing amino acid (not a classical carboxylate-containing amino acid) with a sulfuryl group (\text{SO}_3^-) instead of a carboxyl group.
    • Taurine conjugation in the liver forms taurocholate with bile acids (detergent function for fat digestion and absorption of fat-soluble vitamins).
    • Taurine roles: important in cardiovascular, skeletal, and nervous system function (e.g., osmoregulation, calcium modulation, antioxidant activity, neurotransmission); commonly present in energy drinks (noting variability and context).
  • Summary of integration
    • Glycine, serine, and taurine are interconnected through one-carbon metabolism and sulfur amino acid chemistry, influencing nucleotide synthesis, methylation, and bile-acid physiology
Aromatic Amino Acids: Phenylalanine, Tyrosine, and Related Diseases
  • Phenylalanine to tyrosine pathway
    • Phenylalanine hydroxylase (PAH) converts phenylalanine to tyrosine; deficiency in PAH or its cofactor, tetrahydrobiopterin (BH4), can cause phenylketonuria (PKU).
  • Aromatic amino-acid degradation and disease links
    • Tyrosine catabolism tracks through homogentisate to maleylacetoacetate and beyond, eventually yielding fumarate and acetoacetate. Pathologies include alkaptonuria when homogentisate oxidase is deficient, leading to accumulation of homogentisate, which oxidizes to a black pigment in urine and connective tissues.
    • Downstream metabolism connects to TCA cycle intermediates like fumarate and succinyl-CoA
    • Propagation includes methylmalonic acid formation in certain metabolic derangements
  • Methionine, homocysteine, and methyltransfer reactions
    • Cystathionine and homocysteine metabolism intersect with B12 and B6 cofactors; s-adenosylmethionine (SAM) and s-adenosylhomocysteine (SAH) cycle regulate methylation reactions throughout the body, affecting gene expression, neurotransmitter synthesis, and phospholipid turnover.
  • Related metabolic conditions highlighted in the slide
    • Methylmalonic aciduria: methylmalonyl-CoA mutase deficiency, or defects in vitamin B12 metabolism required by the mutase. It results in the accumulation of methylmalonic acid in the blood and urine; may reflect abnormal odd-chain fatty acid degradation and B12-related issues; can cause severe metabolic acidosis, vomiting, lethargy, developmental delay, and neurodevelopmental problems.
    • Phenylketonuria (PKU): Inherited deficiency in PAH (classic PKU) or BH4 synthesis/regeneration (malignant PKU). Leads to accumulation of phenylalanine and its neurotoxic byproducts (e.g., phenylketones), causing severe intellectual disability if untreated.
    • Alkaptonuria: Deficiency in homogentisate oxidase. Leads to homogentisate accumulation, resulting in dark urine, ochronosis (bluish-black pigmentation of cartilage and connective tissues), and severe early-onset arthritis.
  • Key takeaway
    • Aromatic amino acid metabolism links to energy pathways, neurotransmitter synthesis, and multiple inherited metabolic disorders (PKU, alkaptonuria, methylmalonic aciduria) with profound clinical significance in diagnosis and treatment
Summary: Integrated Takeaways and Clinical Connections
  • Tryptophan degradation routes and clinical implications
    • IDO/TDO-initiated kynurenine pathway yields kynurenine, kynurenic acid, and downstream metabolites (e.g., quinolinic acid), contributing to NAD+ biosynthesis and immune modulation.
    • Serotonin and melatonin branches illustrate how tryptophan fate intersects with mood, sleep, and circadian biology.
    • Immune tolerance and cancer therapy relevance: IDO is a pharmacologic target due to its immunomodulatory effects (e.g., by depleting tryptophan and influencing T-cell activity).
    • Formate production links to one-carbon metabolism and THF cycling
  • BCAA catabolism and MSUD as a metabolic model
    • BCAT and BCKD control degradation of leucine, isoleucine, valine. The BCKD complex's E1, E2, E3 components underscore its multi-enzymatic nature and cofactor requirements.
    • MSUD arises from BCKD deficiency, leading to neurotoxic accumulation of BCAAs and BCKAs; dietary management is essential from birth to prevent severe neurological damage; high incidence in specific populations underscores genetic founder effects.
  • Histidine catabolism and histidinemia
    • Histidine degradation proceeds to FIGLU and THF-linked steps; histidase deficiency causes histidinemia with distinct skin/liver expression patterns and diagnostic skin biopsy confirmation. The role of urocanate in the skin's UV protection is notable.
  • Carnitine and creatine synthesis connect energy storage and transfer to amino acid metabolism
    • Carnitine from lysine supports transport of long-chain fatty acids into mitochondria, critical for beta-oxidation and energy production.
    • Creatine synthesis provides rapid ATP buffering in muscle/brain via phosphocreatine, serving as high-energy reserve; creatinine serves as a diagnostic marker of muscle turnover and, importantly, kidney function (GFR).
  • One-carbon metabolism and folate biology in health and disease
    • THF derivatives shuttle one-carbon units for nucleotide synthesis (purines, thymidylate) and methionine synthesis. The folate trap concept links B12 deficiency to impaired DNA synthesis and megaloblastic anemia, affecting rapidly dividing cells.
    • Therapeutic and pharmacologic implications include MTX, sulfonamides, trimethoprim, and pyrimethamine targeting folate pathways in cancer and infections due to their roles in DNA synthesis.
  • Glycine/serine and taurine in metabolism and physiology
    • SHMT-catalyzed reactions connect serine, glycine, and one-carbon pools; glycine supports multiple biosynthetic pathways (e.g., collagen, heme, purine) and neurotransmission; taurine contributes to bile acid conjugation and various physiological roles including cardiovascular, nervous system, and osmoregulation.
  • Aromatic amino acids and metabolic diseases provide clinical context for diagnosis and management
    • PKU, alkaptonuria, and methylmalonic aciduria illustrate why understanding amino acid catabolism is essential for recognizing metabolic disorders and applying appropriate interventions to prevent severe complications.
  • Core numerical and conceptual anchors to remember
    • MSUD incidence: \sim 1 in 185,000 newborns; Mennonite population risk \sim 1 in 175
    • Histidinemia frequency: \sim 1 in 10,000
    • Key cofactor set for BCAA degradation: TLCFN (TPP, Lipoate, CoA, FAD, NAD+)
    • dTMP synthesis requires \text{5,10-methylene-THF} as a cofactor
      -